2017
DOI: 10.1002/pd.5139
|View full text |Cite
|
Sign up to set email alerts
|

Fetoscopic tracheal occlusion for treatment of non‐isolated congenital diaphragmatic hernia

Abstract: Fetoscopic endotracheal occlusion (FETO) is a prenatal treatment that may increase survival in severe congenital diaphragmatic hernia (CDH). In the USA, FETO is offered for isolated severe left-sided CDH in the context of an FDA-approved feasibility study. FETO in non-isolated cases of severe CDH is only performed with a compassionate use exemption from US regulatory bodies. Anomalies frequently associated with CDH include congenital cystic lesions of the lung and cardiac defects. We describe two cases of non-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 17 publications
0
6
0
Order By: Relevance
“…17 The strategy to induce lung growth in CDH through the augmentation of transmural (intrapulmonary) pressures has already been applied experimentally in humans by fetoscopic tracheal occlusion (FETO), a procedure performed at our hospital and other selected fetal care centers worldwide. 4,63 During FETO-induced lung growth in experimental models, a marked proliferation of type I alveolar epithelial cells, potentially involving the FGF10-FGFR2b-Sprouty2 pathway, has been shown. 64,65 FETO does not appear to increase NKX2.1 expression in either normal or CDH fetal lungs in late gestational animal models.…”
Section: Discussionmentioning
confidence: 99%
“…17 The strategy to induce lung growth in CDH through the augmentation of transmural (intrapulmonary) pressures has already been applied experimentally in humans by fetoscopic tracheal occlusion (FETO), a procedure performed at our hospital and other selected fetal care centers worldwide. 4,63 During FETO-induced lung growth in experimental models, a marked proliferation of type I alveolar epithelial cells, potentially involving the FGF10-FGFR2b-Sprouty2 pathway, has been shown. 64,65 FETO does not appear to increase NKX2.1 expression in either normal or CDH fetal lungs in late gestational animal models.…”
Section: Discussionmentioning
confidence: 99%
“…In most cases, the earlier the prenatal diagnosis of CDH is, the more severe the disease is. The LHR measured by B-mode ultrasound at different stages is an important indicator of the severity of diaphragmatic hernia [15, 16]. After ventilator treatment, children with low partial oxygen pressure and / or high partial carbon dioxide pressure in blood that is difficult to correct often need manual ventilation.…”
Section: Discussionmentioning
confidence: 99%
“…For RCDH, fetal therapy is offered in case of severe hypoplasia (o/e LHR < 45%) because they have a predicted survival rate of 17%. For patients who have a more complex presentation with additional findings, a more individualized approach can be taken, yet in the absence of proof of benefit, this is debatable[ 18 , 19 ].…”
Section: Methodsmentioning
confidence: 99%